Suppr超能文献

通过细针穿刺细胞学样本诊断儿童小圆形细胞肿瘤的困难

Difficulties in diagnosing small round cell tumours of childhood from fine needle aspiration cytology samples.

作者信息

Pohar-Marinsek Ziva

机构信息

Department of Cytopathology, Institute of Oncology, Ljubljana, Slovenia.

出版信息

Cytopathology. 2008 Apr;19(2):67-79. doi: 10.1111/j.1365-2303.2008.00555.x.

Abstract

There are four basic reasons for the difficulties in diagnosing small round cell tumours (SRCT) in childhood from fine needle aspiration cytology (FNAC) samples. First, SRCTs are rare and it is difficult for cytopathologists to obtain enough experience for rendering reliable diagnoses. Second, SRCTs are morphologically very similar. Third, many SRCTs do not have specific antigens which could be demonstrated with immunocytochemistry (ICC) or they lose them when poorly differentiated. In addition, cross reactivity exists between some SRCTs. Unstandardized performance of ICC also contributes to the difficulties due to unreliable results. Fourth, suboptimal FNAC samples add additional pitfalls. The latter may be due to partly degenerate samples or to unrepresentative ones in cases where a SRCT is a heterologous component of another nosological entity. Lymphoma, neuroblastoma, nephroblastoma, Ewing's tumour/primitive neuroendocrine tumours and rhabdomyosarcoma are discussed in detail, while other less common SRCTs are mentioned as differential diagnoses when appropriate. The use of cytogenetic and molecular techniques for differentiating between certain SRCTs is helpful in some doubtful cases. However, there are still problems in the use of these techniques, especially their cost which may delay their being introduced in every cytopathology laboratory.

摘要

从细针穿刺细胞学(FNAC)样本诊断儿童小圆形细胞肿瘤(SRCT)存在困难,主要有四个基本原因。其一,SRCT较为罕见,细胞病理学家难以获得足够经验以做出可靠诊断。其二,SRCT在形态学上非常相似。其三,许多SRCT没有可通过免疫细胞化学(ICC)显示的特异性抗原,或者在分化差时会丢失这些抗原。此外,一些SRCT之间存在交叉反应。ICC操作不规范也因结果不可靠而增加了诊断难度。其四,FNAC样本质量欠佳增加了更多诊断陷阱。后者可能是由于样本部分退变,或者在SRCT是另一种疾病实体的异源成分的情况下样本不具代表性。本文将详细讨论淋巴瘤、神经母细胞瘤、肾母细胞瘤、尤因肉瘤/原始神经内分泌肿瘤和横纹肌肉瘤,同时在适当情况下提及其他不太常见的SRCT作为鉴别诊断。在某些疑难病例中,使用细胞遗传学和分子技术区分特定的SRCT是有帮助的。然而,这些技术的应用仍存在问题,尤其是其成本可能会延迟它们在每个细胞病理学实验室的引入。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验